Cargando…
Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma
Canine hemangiosarcoma (HSA) is a progressive malignant neoplasm of dogs for which there is currently no effective treatment. A recent study suggested that receptor tyrosine kinases (RTKs), the PI3K/Akt/m-TOR and MAPK pathways are all activated in canine and human HSA. The aim of the present study w...
Autores principales: | ADACHI, Mami, HOSHINO, Yuki, IZUMI, Yusuke, TAKAGI, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873857/ https://www.ncbi.nlm.nih.gov/pubmed/26685984 http://dx.doi.org/10.1292/jvms.15-0625 |
Ejemplares similares
-
Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets
por: Pimentel, Pedro Antônio Bronhara, et al.
Publicado: (2023) -
Hyperferritinemia in Dogs with Splenic Hemangiosarcoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013) -
Clinical features and prognosis of retroperitoneal hemangiosarcoma in dogs with surgical resection with or without adjuvant doxorubicin
por: ICHIMATA, Masanao, et al.
Publicado: (2023) -
Epidemiological, Clinical and Pathological Features of Primary Cardiac
Hemangiosarcoma in Dogs: A Review of 51 Cases
por: YAMAMOTO, Shinya, et al.
Publicado: (2013) -
Immunohistochemical detection of p53 and pp53 Ser(392) in canine hemangiomas and hemangiosarcomas located in the skin
por: García-Iglesias, María José, et al.
Publicado: (2020)